Skip to main content

Articles

Page 71 of 335

  1. Osteosarcoma (OS) is a differentiation disease caused by the genetic and epigenetic differentiation of mesenchymal stem cells into osteoblasts. OS is a common, highly malignant tumor in children and adolescent...

    Authors: Pei Zhang, Keteng Xu, Jingcheng Wang, Jiale Zhang and Huahong Quan
    Citation: BMC Cancer 2021 21:1285
  2. The purpose of this phase II study was to evaluate the feasibility of hypofractionated radiotherapy (HFRT) with a dose of 36.5 Gy in 10 fractions in postmastectomy patients.

    Authors: Huayong Jiang, Lingling Meng, Huijuan Zhang, Xiangkun Dai, Qian Zhang, Zhongjian Ju, Wei Yu and Lin Ma
    Citation: BMC Cancer 2021 21:1284
  3. Cancer stem cells (CSCs) drive tumor initiation and progression and participate in tumor chemoresistance. We recently discovered that oral squamous cell carcinoma (OSCC) cells that highly express CD10 (CD10H c...

    Authors: Yinfei Pu, Qingxiang Li, Yifei Wang, Le Xu, Qiao Qiao, Yuxing Guo and Chuanbin Guo
    Citation: BMC Cancer 2021 21:1283
  4. The mean platelet volume/platelet count ratio (MPV/PC) ratio based on the preoperative peripheral MPV and PCcan be used to predict the prognosis of multiple malignant tumors.

    Authors: Qicheng Deng, Qifang Long, Yanan Liu, Zhujuan Yang, Yibei Du and Xin Chen
    Citation: BMC Cancer 2021 21:1282
  5. The aim of this prospective phase II study was to evaluate the efficacy and safety of biweekly docetaxel plus androgen-deprivation therapy (ADT) in patients with metastatic castration-naïve prostate cancer (mC...

    Authors: Seonggyu Byeon, Hongsik Kim, Hwang Gyun Jeon, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee, Soon Il Lee and Se Hoon Park
    Citation: BMC Cancer 2021 21:1281
  6. Lymph node metastasis (LNM) status is an important prognostic factor that strongly influences the treatment decision of early gastric cancer (EGC). This study aimed to evaluate the pattern and clinical signifi...

    Authors: Wu Yanzhang, Li Guanghua, Zhou Zhihao, Wang Zhixiong and Wang Zhao
    Citation: BMC Cancer 2021 21:1280
  7. Pancreatic cancer risk is poorly quantified in relation to the temporal presentation of medical comorbidities and lifestyle. This study aimed to examine this aspect, with possible influence of demographics.

    Authors: Abu Z. M. Dayem Ullah, Konstantinos Stasinos, Claude Chelala and Hemant M. Kocher
    Citation: BMC Cancer 2021 21:1279
  8. Whereas there are many pharmacological interventions prescribed for patients with advanced anaplastic lymphoma kinase (ALK)- rearranged non-small cell lung cancer (NSCLC), comparative data between novel generatio...

    Authors: Hao-chuan Ma, Yi-hong Liu, Kai-lin Ding, Yu-feng Liu, Wen-jie Zhao, Yan-juan Zhu, Xue-song Chang, Ya-dong Chen, Zhen-zhen Xiao, Ya-ya Yu, Rui Zhou and Hai-bo Zhang
    Citation: BMC Cancer 2021 21:1278
  9. Population-based patient reported outcome data in oesophageal cancer are rare. The main purpose of this study was to describe health-related quality of life (HRQOL) 1 year after the diagnosis of oesophageal ca...

    Authors: Berit Sunde, Mats Lindblad, Marlene Malmström, Jakob Hedberg, Pernilla Lagergren and Magnus Nilsson
    Citation: BMC Cancer 2021 21:1277
  10. Cancer development is strictly correlated to composition and physical properties of the extracellular matrix. Particularly, a higher matrix stiffness has been demonstrated to promote tumor sustained growth. Ou...

    Authors: Changsong Wang, Xiaozhong Jiang, Bin Huang, Wenhao Zhou, Xiao Cui, Chenghong Zheng, Fenghao Liu, Jieling Bi, Yi Zhang, Hong Luo, Lin Yuan, Jianyong Yang and Yu Yu
    Citation: BMC Cancer 2021 21:1276
  11. Most immune-related adverse event (irAE) patterns and treatment guidelines are based on western clinical data. We evaluated the incidence and patterns of irAEs in patients treated with immune-checkpoint inhibi...

    Authors: Nuttapong Ngamphaiboon, Suthinee Ithimakin, Teerada Siripoon, Nattaya Sintawichai and Virote Sriuranpong
    Citation: BMC Cancer 2021 21:1275
  12. The present study compared the effectiveness and toxicity of two treatment modalities, namely radiotherapy combined with nimotuzumab (N) and chemoradiotherapy (CRT) in patients with locally recurrent nasophary...

    Authors: Jing-Feng Zong, Qian-Dong Liang, Qiong-Jiao Lu, Yu-Hong Liu, Han-Chuan Xu, Bi-Juan Chen, Qiao-Juan Guo, Yun Xu, Cai-Rong Hu, Jian-Ji Pan and Shao-Jun Lin
    Citation: BMC Cancer 2021 21:1274
  13. Large-panel genomic tumor testing (GTT) is an emerging technology with great promise but uncertain clinical value. Previous research has documented variability in academic oncologists’ perceptions and use of G...

    Authors: Eric C. Anderson, Alexandra C. Hinton, Christine W. Lary, Anny T. H. R. Fenton, Andrey Antov, Emily Edelman, Petra Helbig, Kate Reed, Susan Miesfeldt, Christian A. Thomas, Michael J. Hall, J. Scott Roberts, Jens Rueter and Paul K. J. Han
    Citation: BMC Cancer 2021 21:1273
  14. Current knowledge about the promotion of long-term physical activity (PA) maintenance in cancer survivors is limited. The aims of this study were to 1) determine the effect of self-regulatory BCTs on long-term...

    Authors: Anne-Sophie Mazzoni, Hannah L. Brooke, Sveinung Berntsen, Karin Nordin and Ingrid Demmelmaier
    Citation: BMC Cancer 2021 21:1272
  15. Recent data has demonstrated that hypoxia drives an immunosuppressive tumour microenvironment (TME) via various mechanisms including hypoxia inducible factor (HIF)-dependent upregulation of programmed death li...

    Authors: Vicky Smith, Debayan Mukherjee, Sapna Lunj, Ananya Choudhury, Peter Hoskin, Catharine West and Tim Illidge
    Citation: BMC Cancer 2021 21:1271
  16. To assess the long-term prognosis for patients with iris melanomas and compare it with the prognosis for small choroidal melanomas.

    Authors: Shiva Sabazade, Christina Herrspiegel, Viktor Gill and Gustav Stålhammar
    Citation: BMC Cancer 2021 21:1270

    The Correction to this article has been published in BMC Cancer 2022 22:32

  17. Entinostat is an oral inhibitor of class I histone deacetylases intended for endocrine therapy-resistant patients with hormone receptor-positive (HR+) advanced or metastatic breast cancer (BC). We examined the...

    Authors: Norikazu Masuda, Kenji Tamura, Hiroyuki Yasojima, Akihiko Shimomura, Masataka Sawaki, Min-Jung Lee, Akira Yuno, Jane Trepel, Ryoko Kimura, Yozo Nishimura, Shigehira Saji and Hiroji Iwata
    Citation: BMC Cancer 2021 21:1269
  18. Radiomics may provide more objective and accurate predictions for extrahepatic cholangiocarcinoma (ECC). In this study, we developed radiomics models based on magnetic resonance imaging (MRI) and machine learn...

    Authors: Yong Tang, Chun Mei Yang, Song Su, Wei Jia Wang, Li Ping Fan and Jian Shu
    Citation: BMC Cancer 2021 21:1268
  19. Bladder cancer (BC) is one of the most common malignancies and has a relatively poor outcome worldwide. In this study, we attempted to construct a novel metabolism-related gene (MRG) signature for predicting t...

    Authors: Xiaotao Li, Shi Fu, Yinglong Huang, Ting Luan, Haifeng Wang and Jiansong Wang
    Citation: BMC Cancer 2021 21:1267
  20. N6-methyladenine (m6A) is the most common modification of mRNA and IncRNA in higher organisms. m6A has been confirmed to be related to the formation and progression of tumors and m6A-related genes can be used as ...

    Authors: Jialin Qu, Li Wang, Man Jiang, Zhimin Wei, Guangming Fu and Xiaochun Zhang
    Citation: BMC Cancer 2021 21:1265
  21. Realistic pre-treatment expectations are important and have been associated with post-treatment health related quality of life (HRQOL). Patient expectations are greatly influenced by physicians, as they are th...

    Authors: Anne L. Versteeg, Roxanne Gal, Raphaele Charest-Morin, Jorrit-Jan Verlaan, Hester Wessels, Charles G. Fisher and Helena M. Verkooijen
    Citation: BMC Cancer 2021 21:1263
  22. Despite lower cancer incidence rates, cancer mortality is higher among rural compared to urban dwellers. Patient, provider, and institutional level factors contribute to these disparities. The overarching obje...

    Authors: Tuya Pal, Pamela C. Hull, Tatsuki Koyama, Phillip Lammers, Denise Martinez, Jacob McArthy, Emma Schremp, Ann Tezak, Anne Washburn, Jennifer G. Whisenant and Debra L. Friedman
    Citation: BMC Cancer 2021 21:1262
  23. Some studies have shown that Immune checkpoint inhibitors (ICIs) have a favorable efficacy in advanced triple negative breast cancer (TNBC) patients, but the results are controversial in neoadjuvant chemothera...

    Authors: Yuanfang Xin, Guoshuang Shen, Yonghui Zheng, Yumei Guan, Xingfa Huo, Jinming Li, Dengfeng Ren, Fuxing Zhao, Zhen Liu, Zitao Li and Jiuda Zhao
    Citation: BMC Cancer 2021 21:1261
  24. To determine whether additional chemotherapy after concurrent chemoradiation (CCRT) improves survival outcomes in patients with early cervical cancer who undergo radical hysterectomy (RH).

    Authors: Se Ik Kim, Jeong Yun Kim, Chan Woo Wee, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Taek Sang Lee, Hye Won Jeon, Noh Hyun Park, Yong Sang Song and Tae Hun Kim
    Citation: BMC Cancer 2021 21:1260
  25. Gonadotropin Releasing Hormones agonists (GnRH), which are first line treatment for metastatic prostate cancer (PCa), increase risk of type 2 diabetes mellitus (T2DM). This study aims to quantify the associati...

    Authors: E. Lin, Hans Garmo, Mieke Van Hemelrijck, Jan Adolfsson, Pär Stattin, Björn Zethelius and Danielle Crawley
    Citation: BMC Cancer 2021 21:1259
  26. Studies have indicated that individuals taking aspirin have a reduced risk of cancers and have also established chemo-preventive benefit of aspirin in colorectal cancer. However, research on the association be...

    Authors: Min-Chun Chuang, Yao-Hsu Yang, Meng-Jer Hsieh, Yu-Ching Lin, Tsung-Ming Yang, Pau-Chung Chen and Ming-Szu Hung
    Citation: BMC Cancer 2021 21:1257
  27. Bladder cancer (BLCA) typically has a poor prognosis due to high relapse and metastasis rates. A growing body of evidence indicates that N6-methyladenosine (m6A) and long non-coding RNAs (lncRNAs) play crucial...

    Authors: Tianming Ma, Xiaonan Wang, Lingfeng Meng, Xiaodong Liu, Jiawen Wang, Wei Zhang, Zijian Tian and Yaoguang Zhang
    Citation: BMC Cancer 2021 21:1256
  28. Fatty acid metabolism is reportedly associated with various cancers. However, the role of pretreatment serum free fatty acid (FFA) levels in diffuse large B-cell lymphoma (DLBCL) prognosis is still unclear, an...

    Authors: Liping Fan, Qiuyan Lin, Xiaoling Huang, Danhui Fu and Haobo Huang
    Citation: BMC Cancer 2021 21:1255
  29. Although perineural invasion (PNI) is well-known to be correlated with and able to predict lymph node metastasis (LNM) in oral squamous cell carcinoma (OSCC), the clinical and molecular correlation between PNI...

    Authors: Yu Zhang, Mingtao Chen, Zheqi Liu, Xu Wang and Tong Ji
    Citation: BMC Cancer 2021 21:1254
  30. This study aimed to present the performance of the National Cancer Network’s (NCN) pilot program in the Lower Silesian Voivodeship (southwestern province of Poland with a population of 2,9 million in 2019), to...

    Authors: Łukasz Trembecki, Aleksandra Sztuder, Ireneusz Pawlak, Rafał Matkowski and Adam Maciejczyk
    Citation: BMC Cancer 2021 21:1252
  31. Breast cancer surgery frequently causes deficiencies in shoulder functioning. The study pourpode is to identify risk factors for prolonged pain, reduction in function, and decrease in range of motion (ROM) in ...

    Authors: Ifat Klein, Leonid Kalichman, Noy Chen and Sergio Susmallian
    Citation: BMC Cancer 2021 21:1251
  32. In patients with papillary thyroid cancer (PTC), cervical lymph node metastasis (LNM) must be carefully assessed to determine the extent of lymph node dissection required and patient prognosis. Few studies att...

    Authors: Lei Ye, Lei Hu, Weiyong Liu, Yuanyuan Luo, Zhe Li, Zuopeng Ding, Chunmei Hu, Lin Wang, Yajuan Zhu, Le Liu, Xiaopeng Ma, Yuan Kong and Liangliang Huang
    Citation: BMC Cancer 2021 21:1250

    The Correction to this article has been published in BMC Cancer 2022 22:194

  33. Glioblastoma is a fatal brain tumour with a poor patient survival outcome. Hypoxia has been shown to reprogram cells towards a stem cell phenotype associated with self-renewal and drug resistance properties. A...

    Authors: Lucy Wanjiku Macharia, Wanjiru Muriithi, Carlos Pilotto Heming, Dennis Kirii Nyaga, Veronica Aran, Marianne Wanjiru Mureithi, Valeria Pereira Ferrer, Attilio Pane, Paulo Niemeyer Filho and Vivaldo Moura-Neto
    Citation: BMC Cancer 2021 21:1248
  34. Local ablative therapy (LAT) may be beneficial for patients with epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer (NSCLC) with oligo-residual disease after treatment with EGFR tyrosine k...

    Authors: Taichi Miyawaki, Hirotsugu Kenmotsu, Hiroaki Kodama, Naoya Nishioka, Eriko Miyawaki, Nobuaki Mamesaya, Haruki Kobayashi, Shota Omori, Ryo Ko, Kazushige Wakuda, Akira Ono, Tateaki Naito, Haruyasu Murakami, Keita Mori, Hideyuki Harada, Masahiro Endo…
    Citation: BMC Cancer 2021 21:1247
  35. Atypical tumor response patterns during immune checkpoint inhibitor therapy pose a challenge to clinicians and investigators in immuno-oncology practice. This study evaluated tumor burden dynamics to identify ...

    Authors: Peiyi Xie, Hong Zheng, Haiyang Chen, Kaikai Wei, Ximin Pan, Qinmei Xu, Yongchen Wang, Changguan Tang, Olivier Gevaert and Xiaochun Meng
    Citation: BMC Cancer 2021 21:1246
  36. The genetic changes underlying carcinogenesis in patients with risk factors of gallbladder carcinoma (GBC) remains controversial, especially in patients with pancreaticobiliary maljunction (PBM). This study ai...

    Authors: Satoshi Kawakami, Shinichi Takano, Mitsuharu Fukasawa, Hiroko Shindo, Ei Takahashi, Yoshimitsu Fukasawa, Hiroshi Hayakawa, Natsuhiko Kuratomi, Makoto Kadokura, Naohiro Hosomura, Hidetake Amemiya, Hiromichi Kawaida, Hiroshi Kono, Shinya Maekawa, Daisuke Ichikawa and Nobuyuki Enomoto
    Citation: BMC Cancer 2021 21:1245
  37. The BOLT study for sonidegib, a Hedgehog pathway inhibitor (HHI) approved for patients with locally advanced basal cell carcinoma (laBCC) not amenable to curative surgery or radiotherapy, used modified Respons...

    Authors: Ralf Gutzmer, Caroline Robert, Carmen Loquai, Dirk Schadendorf, Nicholas Squittieri, Ramon Arntz, Serena Martelli and Reinhard Dummer
    Citation: BMC Cancer 2021 21:1244
  38. Molecular differences in colorectal cancer (CRC) are associated with the metastatic route. Patient survival is mainly driven by metastatic spread thus it is imperative to understand its key drivers to develop ...

    Authors: Sven Jacob, Florian Bösch, Markus B. Schoenberg, Elise Pretzsch, Christopher Lampert, Ren Haoyu, Bernhard W. Renz, Marlies Michl, Jörg Kumbrink, Thomas Kirchner, Jens Werner, Martin K. Angele and Jens Neumann
    Citation: BMC Cancer 2021 21:1243
  39. Malignant glioma cell line models are integral to pre-clinical testing of novel potential therapies. Accurate prediction of likely efficacy in the clinic requires that these models are reliable and consistent....

    Authors: Michael T. C. Poon, Morgan Bruce, Joanne E. Simpson, Cathal J. Hannan and Paul M. Brennan
    Citation: BMC Cancer 2021 21:1240
  40. According to current guidelines, treatment of patients with hepatic oligometastasis in pancreatic cancer is not reflected and systemic chemotherapy is recommended in those patients. Retrospective data suggest ...

    Authors: Florian Gebauer, Alexander Ioannis Damanakis, Felix Popp, Alexander Quaas, Fabian Kütting, Katrin Lutz, Swantje Held, Burkhard Deuß, Tobias Göser, Dirk Waldschmidt and Christiane Bruns
    Citation: BMC Cancer 2021 21:1239
  41. Window-of-opportunity trials, evaluating the engagement of drugs with their biological target in the time period between diagnosis and standard-of-care treatment, can help prioritise promising new systemic tre...

    Authors: Stephan Ursprung, Helen Mossop, Ferdia A. Gallagher, Evis Sala, Richard Skells, Jamal A. N. Sipple, Thomas J. Mitchell, Anita Chhabra, Kate Fife, Athena Matakidou, Gemma Young, Amanda Walker, Martin G. Thomas, Mireia Crispin Ortuzar, Mark Sullivan, Andrew Protheroe…
    Citation: BMC Cancer 2021 21:1238
  42. The types of outcomes measured collected in clinical studies and those required for cost-effectiveness analysis often differ. Decision makers routinely use quality adjusted life years (QALYs) to compare the be...

    Authors: Laura A. Gray, Monica Hernandez Alava and Allan J. Wailoo
    Citation: BMC Cancer 2021 21:1237

    The Correction to this article has been published in BMC Cancer 2022 22:112

  43. In contrast to head and neck squamous cell carcinoma (HNSCC), the effect of treatment duration in HNSCC-CUP has not been thoroughly investigated. Thus, this study aimed to assess the impact of the time interva...

    Authors: Matthias Balk, Robin Rupp, Konstantin Mantsopoulos, Moritz Allner, Philipp Grundtner, SK Mueller, Maximilian Traxdorf, Markus Eckstein, Stefan Speer, Sabine Semrau, Rainer Fietkau, Heinrich Iro, Markus Hecht and Antoniu-Oreste Gostian
    Citation: BMC Cancer 2021 21:1236

Featured videos

View featured videos from across the BMC-series journals